Details for New Drug Application (NDA): 209951
✉ Email this page to a colleague
The generic ingredient in FENOFIBRATE is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
Summary for 209951
Tradename: | FENOFIBRATE |
Applicant: | Amneal |
Ingredient: | fenofibrate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 209951
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FENOFIBRATE | fenofibrate | TABLET;ORAL | 209951 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-1260 | 69238-1260-9 | 90 TABLET in 1 BOTTLE (69238-1260-9) |
FENOFIBRATE | fenofibrate | TABLET;ORAL | 209951 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-1261 | 69238-1261-9 | 90 TABLET in 1 BOTTLE (69238-1261-9) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 48MG | ||||
Approval Date: | Feb 9, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 145MG | ||||
Approval Date: | Feb 9, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription